ClinicalTrials.gg
Enrolling by invitationNCT05262894GasPropUpdated Mar 2, 2022

Evaluation of Gas Propagation in Snow During Breathing of Subjects Under Simulated Avalanche Snow

An interventional study of extreme hypercapnia induced by ventilation insufficiency in Accident Caused by Snow Avalanche, sponsored by Czech Technical University in Prague. Enrolling by invitation at 1 site in Czechia. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-02.

Sponsored by Czech Technical University in Prague · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The study is aimed at investigation of respiratory gases propagation in snow. The study involves volunteers breathing into the snow whereas concentrations of gases are measured at various positions in the snow.

Read the detailed description

The study is aimed at investigation of respiratory gases (oxygen and carbon dioxide) propagation in the simulated avalanche snow. The study involves volunteers breathing into the snow whereas concentrations of gases are measured at various positions in the snow. A special apparatus was created for sampling and measurement of gas concentrations and to assure stable geometry of the experiment required for data evaluation.

02

Conditions studied

  • Accident Caused by Snow Avalanche

Browse trials for

Keywords

  • snow
  • avalanche
  • hypercapnia
  • diffusion
03

In context

Hypercapnia

156 studies on the registry are indexed under Hypercapnia; 31 are open to participants now.

This study's planned enrollment of 50 is above the median of 36 across 120 interventional studies indexed under Hypercapnia.

Browse Hypercapnia studies →

Lead sponsor

Czech Technical University in Prague is the lead sponsor of 36 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy and fit volunteers, classified as The class I
  • without a smoking history

Exclusion criteria

Exclusion Criteria:

  • Tiffeneau Index less than 0.70
  • any cardiovascular or respiratory condition
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Breathing in the snow

    Breathing in the snow using a specially designed apparatus and measuring the respiratory gases distribution in snow.

    Other: extreme hypercapnia induced by ventilation insufficiency

Interventions

  • Otherextreme hypercapnia induced by ventilation insufficiency

    Re-breathing of gas by breathing into the simulated avalanche snow

06

What researchers measure

Primary outcomes

  1. The length of breathing

    Time to termination of the breathing experiment due to the decision of the tested subject, or determined by high end-tidal carbon dioxide value or by the order by the clinician assessing the health status of the subjects.

    Time frame: Continuously within up to 20 minute interval from the beginning of the breathing experiment

07

Study locations

1 site
  • Czech Technical University, Faculty of Biomedical Engineering
    Kladno, 272 01, Czechia
08

References and documents

Publications

  • Roubik K, Sieger L, Sykora K. Work of Breathing into Snow in the Presence versus Absence of an Artificial Air Pocket Affects Hypoxia and Hypercapnia of a Victim Covered with Avalanche Snow: A Randomized Double Blind Crossover Study. PLoS One. 2015 Dec 14;10(12):e0144332. doi: 10.1371/journal.pone.0144332. eCollection 2015. PubMed 26666523 ↗
  • Roubik K, Sykora K, Sieger L, Ort V, Horakova L, Walzel S. Perlite is a suitable model material for experiments investigating breathing in high density snow. Sci Rep. 2022 Feb 8;12(1):2070. doi: 10.1038/s41598-022-06015-y. PubMed 35136116 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for May 2025, 39 months after the start.

Of 50 non-industry interventional studies with no phase under Hypercapnia, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 32. This study's planned 39 months is above that.

Counting every sponsor, half of 54 studies reached it within 14 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2022
First posted
Mar 2, 2022
StartActual
Feb 7, 2022
Primary completionEst.
May 31, 2025
CompletionEst.
May 31, 2025
Last update
Mar 2, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05262894
Lead sponsor
Czech Technical University in Prague
Responsible party
Sponsor
First posted
Mar 2, 2022
Start date
Feb 7, 2022
Primary completion
May 31, 2025 (estimated)
Completion
May 31, 2025 (estimated)
Last update
Mar 2, 2022

Study contacts

Karel Roubik, prof.
principal investigator · Czech Technical University in Prague, Fac. of Biomedical Engineering

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion